Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, CA (DDS, KCY-W, CIC, SAS); Kaiser Permanente Northern California, Division of Research, Oakland, CA (DDS, EI, KCY-W, CIC, ASL, SAS); Addiction Medicine and Recovery Services, Kaiser Permanente San Francisco Medical Center, San Francisco, CA (MG).
Send correspondence to Derek D. Satre, PhD, Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, 401 Parnassus Avenue, Box 0984, San Francisco, CA 94143. E-mail: [email protected].
Received 25 May, 2020
Accepted 4 September, 2020
The authors were supported by grants from the National Institute on Alcohol Abuse and Alcoholism (K24AA025703 [Satre]; R01AA025902, R01AA027477 [Sterling]) and the National Institute on Drug Abuse (DA043604 [Young-Wolff]).
The authors report no conflicts of interest.
